REFRACTORY ACUTE BIPHENOTYPIC LEUKEMIA

Clinical trials for REFRACTORY ACUTE BIPHENOTYPIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY ACUTE BIPHENOTYPIC LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY ACUTE BIPHENOTYPIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

New hope for tough leukemias: testing a powerful drug cocktail

Disease control Recruiting now

This study is testing a new combination of cancer drugs for adults with aggressive forms of acute myeloid leukemia (AML) and related blood cancers that are newly diagnosed as high-risk or have come back after previous treatment. The goal is to find the safest and most effective d…

Matched conditions: REFRACTORY ACUTE BIPHENOTYPIC LEUKEMIA

Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control

Last updated Mar 27, 2026 12:37 UTC

REFRACTORY ACUTE BIPHENOTYPIC LEUKEMIA

Get alerted when new REFRACTORY ACUTE BIPHENOTYPIC LEUKEMIA trials appear

New hope for tough leukemias: testing a powerful drug cocktail